Unlock stock picks and a broker-level newsfeed that powers Wall Street.
A Look at Global Investor Charles De Vaulx's Top 5 Holdings

Charles De Vaulx of the IVA Funds reported his third quarter holdings this past week. This year the IVA Funds will celebrate their sixth year in the business. The fund maintains a dual investment approach which is split into short- and long-term investments. IVA reports that their short-term (12 to 18 months) investments are in order to preserve capital while their longer term (5 to 10 years) they try to perform better that their equity benchmark. The fund also reported that over the past five years, they achieved both of these goals with their investments.

Over the past quarter Charles De Vaulx in his IVA Worldwide Fund bought three new stocks bringing the total number of stocks to 97 valued at $5.377 billion. The following five companies are De Vaulx's largest holdings as of the close of the third quarter.


Astellas Pharma (TSE:4503)

The guru's largest holding is in Astellas Pharma where he holds on to 27,439,100 shares of the company's stock. His holdings make up for 7.6% of his total portfolio and 1.24% of the company's shares outstanding.

The guru cut his holdings a minor -0.14% over the past quarter by selling 37,900 shares of the company's stock. He sold these shares near the estimated average quarterly price of �1469.83 per share, and since then the price per share has increased 16.6%.

Charles De Vaulx's historical holdings as of the close of the third quarter:

1417484168065.png
1417484168065.png

Astellas Pharma Inc is engaged in the business of manufacturing, marketing and import/export of pharmaceuticals. The company's businesses are segmented into pharmaceutical and other.

Astellas Pharma's historical revenue and net income:

1417484231428.png
1417484231428.png

The analysis on Astellas Pharma reports that the company's price is sitting near a 5-year high, its dividend yield is near a 5-year low and the company currently holds no debt.

The Peter Lynch Chart suggests that the company is currently overvalued:

1417484256207.png
1417484256207.png

Astellas Pharma has a market cap of �3765.88 billion. Its shares are currently trading at around �1713.50 with a P/E ratio of 18.60, a P/S ratio of 1.94 and a P/B ratio of 2.47. The company currently holds a dividend yield of around 3.94%.

Nestle SA (XSWX:NESN)

De Vaulx's second largest position over the past quarter was in Nestle SA where he holds on to 4,362,184 shares of the company's stocks. His holdings make up for 6% of his total portfolio and 0.14% of the company's shares outstanding.

The guru increased his holdings by 1.68% over the past quarter by purchasing a total of 72,060 shares of the company's stock. The guru added these shares to his holdings near the estimated quarterly price range of CHF69.71 per share. Since then the price per share has increased approximately 4.1%.

Charles De Vaulx's historical holding history:

Waiting for permission
Allow microphone access to enable voice search

Try again.